Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;22(1):19-32.
doi: 10.1038/s41577-021-00549-4. Epub 2021 May 17.

Immunobiology and pathogenesis of hepatitis B virus infection

Matteo Iannacone  1   2   3 , Luca G Guidotti  4   5
Affiliations
Review

Immunobiology and pathogenesis of hepatitis B virus infection

Matteo Iannacone et al. Nat Rev Immunol. 2022 Jan.

Abstract

Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the past four decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcome have been largely uncovered. Whereas HBV appears to induce little or no innate immune activation, the adaptive immune response mediates both viral clearance as well as liver disease. Here, we review our current knowledge on the immunobiology and pathogenesis of HBV infection, focusing in particular on the role of CD8+ T cells and on several recent breakthroughs that challenge current dogmas. For example, we now trust that HBV integration into the host genome often serves as a relevant source of hepatitis B surface antigen (HBsAg) expression during chronic infection, possibly triggering dysfunctional T cell responses and favouring detrimental immunopathology. Further, the unique haemodynamics and anatomy of the liver - and the changes they frequently endure during disease progression to liver fibrosis and cirrhosis - profoundly influence T cell priming, differentiation and function. We also discuss why therapeutic approaches that limit the intrahepatic inflammatory processes triggered by HBV-specific T cells might be surprisingly beneficial for patients with chronic infection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Guidotti, L. G. & Chisari, F. V. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. Mech. Dis. 1, 23–61 (2006). - DOI
    1. Locarnini, S., Hatzakis, A., Chen, D.-S. & Lok, A. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J. Hepatol. 62, S76–S86 (2015). - PubMed - DOI
    1. Yuen, M.-F. et al. Hepatitis B virus infection. Nat. Rev. Dis. Primers 4, 18035 (2018). - PubMed - DOI
    1. Revill, P. A. et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol. Hepatol. 4, 545–558 (2019). - PubMed - PMC - DOI
    1. Udompap, P. & Kim, W. R. Development of hepatocellular carcinoma in patients with suppressed viral replication: changes in risk over time. Clin. Liver Dis. 15, 85–90 (2020). - DOI

Publication types

LinkOut - more resources